DCT

1:20-cv-00090

Boehringer Ingelheim Pharma Inc v. Mylan Pharma

General
Filed
05/08/20
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Nature of Suit830 Patent
Judge
Period
PO Win Rate
09/15/21 - 01/25/24
75%
09/14/21 - 09/15/21
50%
Defendant
Party
No Parties
Attorney
No Attorneys